GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

PZ Wind Down PZRXQ · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

PZ Wind Down — daily PZRXQ Delayed
Market value
$1,169
Last close × shares
Volume
250
Shares, 30 Oct 2026

About PZ Wind Down

Its shares trade under the ticker PZRXQ. It has been listed since 18 May 2016. In the fiscal year to 31 December 2015, it reported revenue of $375,000 and a net loss of $7.4m. At that date it held total assets of $3.9m and shareholders' equity of −$48.9m.

PhaseRx, Inc. operates as a biopharmaceutical company that develops a portfolio of mRNA products to correct inherited, life-threatening liver diseases in children. The company is headquartered in Seattle, Washington. The company went IPO on 2016-05-18. The firm's initial product development focus is on urea cycle disorders, a group of rare genetic diseases that generally present before the age of 12 and are characterized by the body's inability to remove ammonia from the blood. The firm's i-ERT approach is enabled by its Hybrid mRNA Technology platform and is applicable to a number of inherited liver diseases. The firm is headquartered in Seattle.

Figures and description from our data supplier, not checked against the company's own report.

More about PZ Wind Down →

Latest on PZ Wind Down

Our reporting

We have not reported on PZ Wind Down yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is PZ Wind Down's ticker?

PZ Wind Down trades as PZRXQ on its US listing, under ISIN US71723F1030.

What was PZ Wind Down's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.